Literature DB >> 25849297

Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.

Luis Valdés1, Esther San-José, Lucía Ferreiro, Antonio Golpe, Francisco-Javier González-Barcala, María E Toubes, María X Rodríguez-Álvarez, José M Álvarez-Dobaño, Nuria Rodríguez-Núñez, Carlos Rábade, Francisco Gude.   

Abstract

INTRODUCTION: The differential diagnosis of malignant and tuberculous pleural effusion is frequently difficult.
OBJECTIVES: The aim of our study is to determine the discrimination value of demographic parameters and different biological markers in pleural fluid.
METHODS: In pleural fluid obtained from 106 patients with tuberculous, 250 with malignant and 218 with miscellaneous pleural effusion, clinical and analytical parameters were analysed, applying polytomous regression analysis and the receiver operating characteristic (ROC) curves.
RESULTS: The three groups could be differentiated using the measured markers. Age, tumour necrosing factor-alpha, lactate dehydrogenase (LDH), adenosine deaminase (ADA), C-reactive protein (CRP) and carcinoembryonic antigen (CEA) were significant predictors for discriminating tuberculous from malignant pleural effusions; nucleated cells, lymphocytes, cholesterol, LDH, ADA, CRP, CEA and CA15.3 distinguish between malignant and miscellaneous pleural effusions. The ROC areas (95% confidence interval) were, 0.973 (0.953, 0.992) for tuberculous, 0.922 (0.900, 0.943) for miscellaneous, and 0.927 (0.907, 0.948) for malignant pleural effusion. The polytomous model correctly classified a significantly high proportion of patients with tuberculosis (85.8%) and cancer (81.6%). The incorrect classification rate was 17.8%, which increased to 19.5% in the correction using bootstrap.
CONCLUSIONS: The results obtained to estimate the probability of tuberculous and malignant pleural effusion confirm that this model achieves a high diagnostic accuracy. This model should be applied to determine which patients with a pleural effusion of unknown origin would not benefit from further invasive procedures.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  differential diagnosis; malignant pleural exudates; pleural effusion; tuberculous pleural exudates

Mesh:

Substances:

Year:  2014        PMID: 25849297     DOI: 10.1111/crj.12125

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  12 in total

1.  Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.

Authors:  Da-Wei Wu; Wei-An Chang; Kuan-Ting Liu; Meng-Chi Yen; Po-Lin Kuo
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

2.  Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.

Authors:  Susana Herrera Lara; Estrella Fernández-Fabrellas; Gustavo Juan Samper; Josefa Marco Buades; Rafael Andreu Lapiedra; Amparo Pinilla Moreno; María Morales Suárez-Varela
Journal:  Lung       Date:  2017-06-27       Impact factor: 2.584

3.  The efficiency of a clinical pathway to guide combined applications of interventional pulmonology in undiagnosed pleural effusions.

Authors:  Yuan Liu; Lili Geng; Jian Xu; Mei Sun; Na Gao; Jing Zhao; Xue Han; Xiaolin Zhang; Xiaohui Zhao; Ling Jiang; Junjun Zhao
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

Review 4.  Advances in the diagnosis of tuberculous pleuritis.

Authors:  José M Porcel
Journal:  Ann Transl Med       Date:  2016-08

5.  Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers, Using Mathematical Methods.

Authors:  Reza Darooei; Ghazal Sanadgol; Arman Gh-Nataj; Mehdi Almasnia; Asma Darivishi; Alireza Eslaminejad; Mohammad Reza Raoufy
Journal:  Tanaffos       Date:  2017

6.  Diagnostic value of polymerase chain reaction/acid-fast bacilli in conjunction with computed tomography-guided pleural biopsy in tuberculous pleurisy: A diagnostic accuracy study.

Authors:  Lei Li; Ye Wang; Rui Zhang; Dan Liu; Yalun Li; Yongzhao Zhou; Juan Song; Weimin Li; Panwen Tian
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Development and validation of a novel scoring system developed from a nomogram to identify malignant pleural effusion.

Authors:  Sufei Wang; Shan Tian; Yuan Li; Na Zhan; Yingyun Guo; Yu Liu; Juanjuan Xu; Yanling Ma; Shujing Zhang; Siwei Song; Wei Geng; Hui Xia; Pei Ma; Xuan Wang; Tingting Liao; Yanran Duan; Yang Jin; Weiguo Dong
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

8.  Application of endoscopic ultrasound-guided-fine needle aspiration combined with cyst fluid analysis for the diagnosis of mediastinal cystic lesions.

Authors:  Yuchong Zhao; Ronghua Wang; Yun Wang; Qian Chen; Liangkai Chen; Wei Hou; Limin Liu; Wei Gao; Bin Cheng
Journal:  Thorac Cancer       Date:  2018-11-27       Impact factor: 3.500

9.  Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.

Authors:  Jaehee Lee; Ji Eun Park; Sun Ha Choi; Hyewon Seo; Sang Yub Lee; Jae Kwang Lim; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Chang Ho Kim
Journal:  Korean J Intern Med       Date:  2021-07-15       Impact factor: 2.884

10.  The diagnostic yield of closed needle pleural biopsy in exudative pleural effusion: a retrospective 10-year study.

Authors:  Tianli Zhang; Bing Wan; Li Wang; Chuling Li; Yangyang Xu; Xiangdong Wang; Hongbing Liu; Yong Song; Dang Lin; Ping Zhan; Tangfeng Lv
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.